While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: SVVPHC9B-PS
$500.00
Lentiviral construct expressing the dCas9-VPH complex--a dCas9 activator used with CRISPRa.